2C-P: Difference between revisions

>LockPicker
>Dutchmonster
m Add legality + citation for Netherlands, with a focus on a recent law that is a blanket ban
 
(30 intermediate revisions by 11 users not shown)
Line 1: Line 1:
{{headerpanel|{{Template:Warning/2C-P}}}}
{{SummarySheet}}
{{SummarySheet}}
{{SubstanceBox/2C-P}}
{{SubstanceBox/2C-P}}


'''2,5-Dimethoxy-4-propylphenethylamine''' (also known as '''2C-P''') is a lesser-known novel [[Psychoactive class::psychedelic]] of the [[chemical class::phenethylamine]] class. 2C-P is a relatively obscure member of the [[2C-x]] family of psychedelic phenethylamines and is one of the most potent, long-lasting, and dose-sensitive of the series.  
'''2,5-Dimethoxy-4-propylphenethylamine''' (also known as '''2C-P''') is a lesser-known novel [[Psychoactive class::psychedelic]] substance of the [[chemical class::phenethylamine]] class. 2C-P is a relatively obscure member of the [[2C-x]] family of psychedelic phenethylamines, which are closely related to the classical psychedelic [[mescaline]]. It is known as one of the most potent, dose-sensitive, and long-lasting of the series. Although the precise mechanism is not known, it is thought to produce its psychoactive effects by activating [[serotonin]] [[receptors]] in parts of the brain.


2C-P was first synthesized and tested for human activity by [[Alexander Shulgin]], who documented his findings in the 1991 book [[PiHKAL]] ("Phenethylamines I Have Known and Loved").<ref>https://erowid.org/library/books_online/pihkal/pihkal.shtml | [[PiHKAL]] </ref> The reports found in the 2C-P PiHKAL entry remark on its depth and long onset and duration of action, with the commentary section describing 16 mg as a clear overdose with "physical consequences." The commentary also notes the small window separating an adequate dose from an excessive dose, suggesting it is relatively easy to overdose on.
2C-P was first synthesized and tested for human activity by the American chemist [[Alexander Shulgin]], who documented his findings in the 1991 book [[PiHKAL]] ("Phenethylamines I Have Known and Loved").<ref name="PiHKAL">{{cite book|title=PiHKAL: A Chemical Love Story|title-link=PiHKAL|author-link1=Alexander Shulgin|author1=Alexander Shulgin|author2=Ann Shulgin|year=1991|publisher=Transform Press|location=United States|isbn=0963009605|oclc=1166889264|chapter-url=https://erowid.org/library/books_online/pihkal/pihkal036.shtml|chapter=#36. 2C-P}}</ref> The reports found in the 2C-P PiHKAL entry remark on its depth and long onset and duration of action, with the commentary section describing 16 mg as a clear overdose with "physical consequences." The commentary also notes the small window separating an adequate dose from an excessive dose, suggesting it is relatively easy to overdose on.


User reports following the publication of PiHKAL tend to characterize the effects of 2C-P in terms of its unusually long duration, powerful, sometimes overwhelming visuals, and intense "body load" (such as persisting [[nausea]], [[muscle tension]] and general bodily discomfort). 2C-P's head space and visuals have been described as possessing more similarities to alkylated 2C's like [[2C-E]] than halogenated members like [[2C-B]] or [[2C-I]]. Some reports suggest it may be easier to experience agitation and delirium on 2C-P than other 2C's, perhaps owing to the ease in which it can be mishandled. As a result, it is considered to have a relatively questionable safety profile for a psychedelic.
[[Subjective effects]] include [[geometry|open and closed-eye visuals]], [[time distortion]], [[conceptual thinking]], [[euphoria]], and [[ego loss]]. User reports tend to characterize the effects of 2C-P in terms of its unusually long duration, powerful, sometimes overwhelming visuals, and intense "body load" consisting of [[nausea]], [[muscle tension]], and general bodily discomfort. Some reports suggest it may be easier to experience agitation and [[delirium]] on 2C-P than other 2C's, perhaps owing to the ease in which it can be mis-dosed. As a result, it is considered to have an unfavorable safety profile among psychedelics.  


Due its powerful effects and unusually long duration, 2C-P may be overly intense and difficult to use safely for those who are not already experienced with [[hallucinogens]]. It is strongly advised to use [[harm reduction practices]] if using this substance. Dosing practices like "eye-balling" (i.e. using the naked eye instead of a reliable milligram scale) or non-oral [[routes of administration]] should especially be avoided. [[Volumetric liquid dosing]] is commonly recommended when dealing with substances of this potency.
Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-P. Due its powerful effects and unusually long duration, 2C-P may be overly intense and difficult to use safely for those who are not highly experienced with [[hallucinogens]]. It is strongly advised to use [[harm reduction practices]] if using this substance. These include avoiding "eye-balling" (i.e. measuring the dose with the naked eye instead of a reliable milligram scale) and non-oral [[routes of administration]]. [[Volumetric liquid dosing]] is commonly recommended when dealing with substances of this potency.


==Chemistry==
==Chemistry==
2C-P or 2,5-dimethoxy-4-propylphenethylamine is a substituted [[phenethylamines|phenethylamine]] featuring a phenyl ring bound to an amino (NH<sub>2</sub>) group through an ethyl chain. 2C-P contains methoxy functional groups CH<sub>3</sub>O- attached to carbons R<sub>2</sub> and R<sub>5</sub> and a propyl chain attached to carbon R<sub>4</sub> of the phenyl ring. 2C-P belongs to the 2C family of phenethylamines which contain methoxy groups on the 2 and 5 positions of the benzene ring.<ref>http://isomerdesign.com/PiHKAL/read.php?id=36</ref>
2C-P or 2,5-dimethoxy-4-propylphenethylamine is a substituted [[phenethylamines|phenethylamine]] featuring a phenyl ring bound to an amino (NH<sub>2</sub>) group through an ethyl chain. 2C-P contains methoxy functional groups CH<sub>3</sub>O- attached to carbons R<sub>2</sub> and R<sub>5</sub> and a propyl chain attached to carbon R<sub>4</sub> of the phenyl ring. 2C-P belongs to the 2C family of phenethylamines which contain methoxy groups on the 2 and 5 positions of the benzene ring.<ref name="PiHKAL" />


==Pharmacology==
==Pharmacology==
{{Further|Serotonergic psychedelic}}
{{Further|Serotonergic psychedelic}}
2C-P is a relatively potent and long acting psychedelic phenethylamine of the 2C family which possesses stimulant type effects as well. It was first described by Alexander Shulgin in his book ''[[PiHKAL]]''.
2C-P has been shown to produce a variety of intense [[hallucinogenic]] type effects ranging from drastic changes in consciousness and perception, to open and closed eye visuals. 2C-P is considered to be one of the strongest 2C-x compounds dosage for dosage, rivaled only by 2C-TFM.
2C-P's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how it results in the [[psychedelic]] experience continues to remain elusive.
2C-P's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how it results in the [[psychedelic]] experience continues to remain elusive.


==Subjective effects==
==Subjective effects==
2C-P's head space and visuals have been described as possessing more similarities to alkylated 2C's like [[2C-E]] than halogenated members like [[2C-B]] or [[2C-I]].
{{Preamble/SubjectiveEffects}}
{{Preamble/SubjectiveEffects}}
{{effects/base
{{effects/base
Line 102: Line 109:
{{#ask: [[Category:2C-P]][[Category:Experience]]|format=ul|Columns=1}}
{{#ask: [[Category:2C-P]][[Category:Experience]]|format=ul|Columns=1}}
Additional experience reports can be found here:
Additional experience reports can be found here:
* [https://www.erowid.org/experiences/subs/exp_2CP.shtml Erowid Experience Vaults: 2C-P]
 
*[https://www.erowid.org/experiences/subs/exp_2CP.shtml Erowid Experience Vaults: 2C-P]


==Toxicity and harm potential==
==Toxicity and harm potential==
{{toxicity}}
{{further|Research chemicals#Toxicity and harm potential|Responsible use #Hallucinogens}}
{{further|Research chemicals#Toxicity and harm potential|Responsible use #Hallucinogens}}
The toxicity and long-term health effects of recreational 2C-P use do not seem to have been studied in any scientific context and the exact [[Toxicity::toxic dose is unknown]]. This is because 2C-P is a [[research chemical]] with very little history of human usage.  
The toxicity and long-term health effects of recreational 2C-P use do not seem to have been studied in any scientific context and the exact [[Toxicity::toxic dose is unknown]]. This is because 2C-P is a [[research chemical]] with very little history of human usage.  
Line 114: Line 121:


===Overdose===
===Overdose===
The LD<sub>50</sub> of 2C-P has not been established. However, it is believed that 2C-P is likely to have a smaller therapeutic window compared to other 2C's, meaning a lethal dose may be achieved more easily. 2C-P is known to be highly dose-sensitive: a difference of 2 or 5 milligrams may radically change the nature of the experience along with its safety profile. Users who wish to take high doses of this compound are advised to titrate upward slowly, use reliable milligram scales to measure doses, and avoid non-oral routes of administration such as insufflation or injection.
{{GenericPanel/warning
| title=2C-P is difficult to dose properly, and requires patience. Be aware that impulsive overdosing can lead to an overdose. Please structure a calculated dosage regimen and stick to it.
| content=* 2C-P has a '''steep dose-response curve''': As little as a few extra milligrams separating a manageable dose and an overdose.<ref name="Erowid" /> Users who wish to take high doses of this compound are advised to titrate upward slowly, use reliable milligram scales to measure doses, and avoid non-oral routes of administration such as insufflation or injection.
* 2C-P has a '''very slow onset''': The peak effects reportedly do not occur for 1 to 3 hours.<ref name="Erowid">{{Citation | title=Erowid Online Books : “PIHKAL” - #36 2C-P | url=https://www.erowid.org/library/books_online/pihkal/pihkal036.shtml}}</ref> Thus it's advised to wait for ''at least'' 3 hours before re-dosing is considered, and even longer for full stomach content.
* 2C-P has a '''very long half-life''': The anecdotal estimated elimination half-life is 19 hours.<ref>https://pubmed.ncbi.nlm.nih.gov/28130544/</ref>
}}


In 2017, a 25-year old British female died following the ingestion of a large dose of 2C-P at a music festival.<ref>Morris, S. (2019, February 13). Bestival death may be world's first 2C-P fatality, court hears. Retrieved from https://www.theguardian.com/uk-news/2019/feb/13/bestival-death-may-be-worlds-first-2-cp-fatality-court-hears</ref> No source reported clear evidence that 2C-P by itself led to the immediate death of the female.
The LD<sub>50</sub> of 2C-P has not been established. However, it is believed that 2C-P is likely to have a smaller therapeutic window compared to other 2C's, meaning a lethal dose may be achieved more easily.
 
In 2017, a 25-year old British female died following the ingestion of a large dose of 2C-P at a music festival.<ref>{{cite news|author=Steven Morris|date=February 13, 2019|title=Bestival death may be world's first 2C-P fatality, court hears|url=https://www.theguardian.com/uk-news/2019/feb/13/bestival-death-may-be-worlds-first-2-cp-fatality-court-hears|publisher=The Guardian|access-date=October 12, 2020}}</ref> No source reported clear evidence that 2C-P by itself led to the immediate death of the female.


===Dependence and abuse potential===
===Dependence and abuse potential===
As a [[serotonergic psychedelic]], 2C-P is considered to have a [[Addiction potential::low potential for abuse and dependence]].
As a [[serotonergic psychedelic]], 2C-P is considered to have a [[Addiction potential::low potential for abuse and dependence]].


Tolerance to the effects of 2C-P are built [[Time to full tolerance::almost immediately after ingestion]]. After that, it takes about [[Time to half tolerance::3 days]] for the tolerance to be reduced to half and [[Time to zero tolerance::7 days]] to be back at baseline (in the absence of further consumption). 2C-P produces cross-tolerance with [[Cross-tolerance::all [[psychedelic]]s]], meaning that after the consumption of 2C-P all psychedelics will have a reduced effect.
Tolerance to the effects of 2C-P is built [[Time to full tolerance::almost immediately after ingestion]]. After that, it takes about [[Time to half tolerance::3 days]] for the tolerance to be reduced to half and [[Time to zero tolerance::7 days]] to be back at baseline (in the absence of further consumption). 2C-P produces cross-tolerance with [[Cross-tolerance::all [[psychedelic]]s]], meaning that after the consumption of 2C-P all psychedelics will have a reduced effect.


===Dangerous interactions===
===Dangerous interactions===
{{DangerousInteractions/Intro}}
{{DangerousInteractions/Intro}}
 
{{DangerousInteractions/Psychedelics}}
*'''[[UncertainInteraction::Cannabis]]''' - Cannabis has an unexpectedly strong and somewhat unpredictable synergy with the effects of psychedelics. Extreme caution is advised when using this combination as it can significantly increase the chances of a negative psychological reaction like [[anxiety]], [[paranoia]], [[panic attacks]], and [[psychosis]]. Users are advised to start off with only a fraction of their normal cannabis dose and take long breaks between hits to avoid over intake.
*'''[[UncertainInteraction::Stimulants]]''' - Stimulants affect many parts of the brain. Combined with psychedelics, stimulation can turn into uncontrollable [[anxiety]], [[Panic attacks|panic]], [[thought loops]], and [[paranoia]]. This interaction may result in an elevated risk of [[mania]] and [[psychosis]].{{citation needed}}
*'''[https://en.wikipedia.org/wiki/Lithium_(medication) [[UnsafeInteraction::Lithium]]]''' - Lithium is often prescribed as a treatment for bipolar disorder. It may possibly cause elevated risk of seizures and psychosis due to its [[Glutamate|glutaminergic]] and [[GABA|GABAergic]] effects.{{citation needed}}
*'''[[UnsafeInteraction::Tramadol]]''' - Tramadol lowers the seizure threshold<ref>Talaie, H., Panahandeh, R., Fayaznouri, M. R., Asadi, Z., & Abdollahi, M. (2009). Dose-independent occurrence of seizure with tramadol. Journal of Medical Toxicology, 5(2), 63-67. https://doi.org/10.1007/BF03161089</ref> and [[psychedelics]] may act as triggers for seizures in susceptible individuals.{{citation needed}}


==Legal status==
==Legal status==
2C-P is not scheduled under the UN Convention on Psychotropic Substances. It is considered to exist in a legal grey area in many countries, meaning that while it is not specifically illegal, individuals may still be charged for its possession under certain circumstances such as under analogue laws and with the intent to sell or consume.  
2C-P is not scheduled under the UN Convention on Psychotropic Substances. It is considered to exist in a legal grey area in many countries, meaning that while it is not specifically illegal, individuals may still be charged for its possession under certain circumstances such as under analogue laws and with the intent to sell or consume.  


*'''Austria''': 2C-P is illegal to possess, produce and sell under the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich).{{citation needed}}
*'''Austria''': 2C-P is illegal to possess, produce and sell under the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich). In its Schedule II, the further specifying NPSV (Neue-Psychoaktive-Substanzen-Verordnung Österreich) explicitly bans all substituted phenetylamines.<ref>{{cite web|url=https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642|title=Bundesrecht konsolidiert: Gesamte Rechtsvorschrift für Neue-Psychoaktive-Substanzen-Verordnung|date=June 26, 2019|language=de|access-date=January 10, 2021}}</ref>
*'''Canada''': 2C-P would be considered Schedule III as it is a derivative of 2,5-dimethoxyphenethylamine.<ref>Controlled Drugs and Substances Act (S.C. 1996, c. 19) |http://laws-lois.justice.gc.ca/eng/acts/C-38.8/page-12.html#h-28</ref>
*'''Canada''': 2C-P would be considered Schedule III as it is a derivative of 2,5-dimethoxyphenethylamine.<ref>{{cite web|url=http://isomerdesign.com/Cdsa/schedule.php?schedule=3&section=ALL&structure=C|title=Schedule III|work=Controlled Drugs and Substances Act (CDSA)|publisher=Isomer Design|access-date=October 10, 2020}}</ref>
*'''China''': As of October 2015, 2C-P is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>
*'''China''': As of October 2015, 2C-P is a controlled substance in China.<ref>{{cite web|url=http://www.sfda.gov.cn/WS01/CL0056/130753.html|title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知|publisher=国家食品药品监督管理总局 [China Food and Drug Administration (CFDA)]|date=September 27, 2015|language=zh|archive-url=https://web.archive.org/web/20170906191704/http://www.sfda.gov.cn/WS01/CL0056/130753.html|archive-date=September 6, 2017}}</ref>
*'''Denmark''': 2C-P is on the list of Schedule B controlled substances.<ref>https://www.retsinformation.dk/Forms/R0710.aspx?id=137169</ref>
*'''Denmark''': 2C-P is on the list of Schedule B controlled substances.<ref>{{cite web|url=https://www.retsinformation.dk/Forms/R0710.aspx?id=137169|title=Bekendtgørelse om euforiserende stoffer|access-date=December 10, 2019|language=da|id=BEK Nr. 557|date=May 31, 2011|publisher=Civilstyrelsen [Civil Agency]}}</ref>
*'''Germany''': 2C-P is controlled under Anlage I BtMG (Narcotics Act, Schedule I) as of December 13, 2014.<ref>{{cite web|url=https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl114s1999.pdf#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl114s1999.pdf%27%5D__1576023093735|title=Achtundzwanzigste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften|publisher=Bundesanzeiger Verlag|access-date=December 10, 2019|language=de}}</ref><ref>{{cite web|url=https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html|title=Anlage I BtMG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 10, 2019|language=de}}</ref> It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license.<ref>{{cite web|url=https://www.gesetze-im-internet.de/btmg_1981/__29.html|title=§ 29 BtMG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 10, 2019|language=de}}</ref>
*'''Germany''': 2C-P is controlled under Anlage I BtMG (''Narcotics Act, Schedule I'')<ref>{{cite web|url=https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html|title=Gesetz über den Verkehr mit Betäubungsmitteln: Anlage I|publisher=Bundesamt für Justiz [Federal Office of Justice]|access-date=December 10, 2019|language=de}}</ref> as of December 13, 2014.<ref>{{cite web|url=http://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl114s1999.pdf|title=Achtundzwanzigste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften|publisher=Bundesanzeiger Verlag|work=Bundesgesetzblatt Jahrgang 2014 Teil I Nr. 57|page=1999-2002|publication-date=December 12, 2014|language=de|oclc=231871244|issn=0341-1095|date=December 5, 2014}}</ref> It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license.<ref>{{cite web|url=https://www.gesetze-im-internet.de/btmg_1981/__29.html|title=Gesetz über den Verkehr mit Betäubungsmitteln: § 29|publisher=Bundesamt für Justiz [Federal Office of Justice]|access-date=December 10, 2019|language=de}}</ref>
*'''Latvia''': 2C-P is a Schedule I controlled substance.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (2,5-Dimetoksifeniletānamīni) | http://likumi.lv/doc.php?id=121086</ref>
*'''Japan''': 2C-P is a controlled substance in Japan effective March 25th, 2015.<ref>{{cite web|url=https://www.mhlw.go.jp/stf/houdou/0000078803.html|title=危険ドラッグの成分16物質を新たに指定薬物に指定|publisher=厚生労働省 [Ministry of Health, Labour and Welfare (MHLW)]|access-date=May 2, 2022|language=ja}}</ref>
*'''Switzerland''': Possession, production and sale is illegal.<ref>http://web.archive.org/web/20170329020935/https://www.admin.ch/opc/de/classified-compilation/20101220/index.html</ref>
*'''Latvia''': 2C-P is a Schedule I controlled substance.<ref>{{cite web|url=http://likumi.lv/doc.php?id=121086|title=Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem|publisher=VSIA Latvijas Vēstnesis|access-date=January 1, 2020|publication-date=November 10, 2005|language=lv}}</ref>
*'''United Kingdom''': 2C-P is a Class A drug in the United Kingdom as a result of the phenethylamine catch-all clause.<ref>United Kingdom. (1977). Misuse of Drugs Act 1971 (S.I. 1977/1243). London: The Stationery Office Limited. Retrieved July 5, 2017, from http://www.legislation.gov.uk/uksi/1977/1243/made</ref>
*'''Switzerland''': 2C-P is a controlled substance specifically named under Verzeichnis E.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref>
*'''United States''': 2C-P is a Schedule I controlled substance.<ref>http://www.justice.gov/ola/views-letters/112/093011-ltr-re-hr1254-synthetic-drug-control-act-2011.pdf</ref> This means 2C-P is illegal to manufacture, buy, possess, process, or distribute without a license from the Drug Enforcement Administration (DEA).
*'''Turkey:''' 2C-P is a classed as drug and is illegal to possess, produce, supply, or import.<ref>{{cite web|title=Bakanlar Kurulu Kararı - Karar Sayısı : 2011/1310|url=https://resmigazete.gov.tr/eskiler/2011/02/20110213-4.htm|publisher=Başbakanlık Mevzuatı Geliştirme ve Yayın Genel Müdürlüğü [General Directorate of Legislation Development and Publication]|publication-date=February 13, 2011|date=January 7, 2011|work=Resmî Gazete, Sayı: 27845|language=tr}}</ref>
*'''The Netherlands:''' 2C-P is currently legal, but it is part of a substance group that may be banned soon as part of a recently passed law on New Psychoactive Substances (NPS). <ref>{{Citation|title= Wijziging van de Opiumwet in verband met het toevoegen van een derde lijst met als doel het tegengaan van de productie van en de handel in nieuwe psychoactieve stoffen en enkele andere wijzigingen (Dutch) | year=2024|url=https://www.tweedekamer.nl/kamerstukken/wetsvoorstellen/detail?id=2022Z14042&dossier=36159}}</ref>  
*'''United Kingdom''': 2C-P is a Class A drug in the United Kingdom as a result of the phenethylamine catch-all clause.<ref>{{cite web|title=Schedule 2: Part I: Class A Drugs|url=http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I|work="Misuse of Drugs Act 1971"|access-date=August 20, 2020|publisher=UK Government}}</ref>
*'''United States''': 2C-P is a Schedule I controlled substance.<ref>{{cite letter|url=http://www.justice.gov/ola/views-letters/112/093011-ltr-re-hr1254-synthetic-drug-control-act-2011.pdf|publisher=Office of Legislative Affairs|author=Ronald Weich (Assistant Attorney General)|recipient=F. James Sensenbrenner Jr. (Subcommittee on Crime, Terrorism, and Homeland Security)|date=September 30, 2011|subject=Additional Synthetic Drugs for Inclusion in section 202(c) of the Controlled Substances Act}}</ref> This means 2C-P is illegal to manufacture, buy, possess, process, or distribute without a license from the Drug Enforcement Administration (DEA).


==See also==
==See also==
*[[Responsible use]]
*[[Responsible use]]
**[[Volumetric liquid dosing]]
**[[Volumetric liquid dosing]]
Line 154: Line 168:


==External links==
==External links==
*[https://en.wikipedia.org/wiki/2C-P 2C-P (Wikipedia)]
*[https://en.wikipedia.org/wiki/2C-P 2C-P (Wikipedia)]
*[https://erowid.org/chemicals/2cp/2cp.shtml 2C-P (Erowid Vault)]
*[https://erowid.org/chemicals/2cp/2cp.shtml 2C-P (Erowid Vault)]
*[https://isomerdesign.com/PiHKAL/read.php?domain=pk&id=36 2C-P (PiHKAL / Isomer Design)]
*[https://isomerdesign.com/PiHKAL/read.php?domain=pk&id=36 2C-P (PiHKAL / Isomer Design)]
===Discussion===
===Discussion===
*[http://www.bluelight.org/vb/archive/index.php/t-129380.html The Big & Dandy 2C-P Thread (Bluelight)]
*[http://www.bluelight.org/vb/archive/index.php/t-129380.html The Big & Dandy 2C-P Thread (Bluelight)]


Line 163: Line 180:
<references />
<references />


[[Category:Substance]]
[[Category:Psychoactive substance]]
[[Category:Psychoactive substance]]
[[Category:Hallucinogen]]
[[Category:Psychedelic]]
[[Category:Psychedelic]]
[[Category:Phenethylamine]]
[[Category:2C-x]]
[[Category:2C-x]]
[[Category:Research chemical]]
[[Category:Research chemical]]
Retrieved from "http://psy.st/wiki/2C-P"